As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Bronchiectasis Drugs Market: By Product: Antibiotics, Expectorants, Other Drugs; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand, EMR’s Key Indicators for Price; Competitive Landscape; Industry Events and Developments

Global Bronchiectasis Drugs Market Outlook

The global bronchiectasis drugs market size is projected to expand by USD 126.75 million between 2021 and 2026.

 

Global Bronchiectasis Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Conventional techniques used to diagnose bacterial lung infection have several constraints, including failure to accurately identify the cause of infection and failure to provide a full representation of the bacterial load present in the lungs, thus, leading to the development of advanced technologies like high-resolution computed tomography (HRCT) scan, aiding the bronchiectasis drugs market. Further, the availability of low-cost drugs is one of the major factors aiding the bronchiectasis drugs industry, globally.

 

Properties and Applications

Bronchiectasis can lead to a build-up of excess mucous, making the lungs more vulnerable to infection. The major method to treat bronchiectasis remains the use of antibiotics to avoid infection.

 

Global Bronchiectasis Drugs Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The industry can be broadly categorised on the basis of its product into:

  • Antibiotics
  • Expectorants
  • Others

The EMR report looks into the regional bronchiectasis drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Bronchiectasis Drugs Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The high-resolution computed tomography (HRCT) scan has emerged as popular technique to diagnose bronchiectasis and other respiratory diseases. Such developments in respiratory disease diagnostics will allow pulmonologists and otolaryngologists to accurately define the disease phase and provide patients with suitable and timely therapy and medicines. This trend will have a positive effect over the forecast period on bronchiectasis drugs market growth. Further, the accessibility to low-cost and off-label generic drugs is one of the  major factors responsible for the development of the market. Generic drug contains the same active pharmaceutical ingredient (API) as branded drugs and are less expensive than branded drugs. The availability of such low-priced drugs, combined with rising bronchiectasis incidence, will increase therapeutic adoption rates, particularly in underdeveloped and developing countries. The approval of these low-cost generics will further increase the growth opportunities for market.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global bronchiectasis drugs market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Endo International Plc [NASDAQ: ENDP]
  • GlaxoSmithKline Plc [LON: GSK]
  • Neopharma LLC 
  • Pfizer Inc. [NYSE: PFE]  
  • Reckitt Benckiser Group Plc [LON: RB]  
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Region
Breakup by Product Antibiotics, Expectorants, Other Drugs
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Endo International Plc [ENDP (NASDAQ)], GlaxoSmithKline Plc [GSK (LON)], Neopharma LLC, Pfizer Inc. [PFE (NYSE)], Reckitt Benckiser Group Plc [RB (LON)], Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Bronchiectasis Drugs Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Bronchiectasis Drugs Historical Market (2016-2020) 
    8.3    Global Bronchiectasis Drugs Market Forecast (2021-2026)
    8.4    Global Bronchiectasis Drugs Market by Product
        8.4.1    Antibiotics
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Expectorants
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Other Drugs
    8.5    Global Bronchiectasis Drugs Market by Region
        8.5.1    Market Share
            8.5.1.1    North America
            8.5.1.2    Europe
            8.5.1.3    Asia Pacific
            8.5.1.4    Latin America
            8.5.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Spain
            9.2.3.6    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    GlaxoSmithKline Plc (LON: GSK)
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Neopharma LLC 
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Pfizer Inc. (NYSE: PFE)
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Reckitt Benckiser Group Plc (LON: RB)
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global Bronchiectasis Drugs Market: Key Industry Highlights, 2016 and 2026
2.    Global Bronchiectasis Drugs Historical Market: Breakup by Product (USD Million), 2016-2020
3.    Global Bronchiectasis Drugs Market Forecast: Breakup by Product (USD Million), 2021-2026
4.    Global Bronchiectasis Drugs Historical Market: Breakup by Region (USD Million), 2016-2020
5.    Global Bronchiectasis Drugs Market Forecast: Breakup by Region (USD Million), 2021-2026
6.    North America Bronchiectasis Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
7.    North America Bronchiectasis Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
8.    Europe Bronchiectasis Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
9.    Europe Bronchiectasis Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
10.    Asia Pacific Bronchiectasis Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
11.    Asia Pacific Bronchiectasis Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
12.    Latin America Bronchiectasis Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
13.    Latin America Bronchiectasis Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Middle East and Africa Bronchiectasis Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Middle East and Africa Bronchiectasis Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Global Bronchiectasis Drugs Market Structure

Key Questions Answered in the Report

The global bronchiectasis drugs market is projected to grow by USD 126.75 million between 2021 and 2026.

The major drivers of the market include the several constraints of conventional techniques used to diagnose bacterial lung infection and the rising pharmaceutical industry.

Availability of low-cost drugs is the key industry trend propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading products in the market are antibiotics, expectorants, and other drugs.

The major players in the industry are GlaxoSmithKline Plc, Neopharma LLC, Pfizer Inc., and Reckitt Benckiser Group Plc, among others.

Analyst Review

Aided by the rising investments into the healthcare sector, the global bronchiectasis drugs market is expected to witness a healthy growth in the forecast period of 2021-2026 and expand by USD 126.75 million.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on product, the bronchiectasis drugs industry can be segmented into antibiotics, expectorants, and other drugs. The major regional markets for bronchiectasis drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Endo International Plc, GlaxoSmithKline Plc, Neopharma LLC, Pfizer Inc., Reckitt Benckiser Group Plc, and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER